PLX

#3115
Protalix BioTherapeutics, Inc. Common Stock
2.8300 USD
+1.07%
Secteur: Soins de Santé
Base: USD
Devise de Profit: USD
Range quotidien
2.7890
2.8450
Range Annuel
2.5850
3.1900
Changement quotidien
+1.07%
Changement Mensuel
-3.08%
Evolution sur 6 mois
-3.08%
Changement Annuel
-3.08%
Clôture Précédente
2.8000
Open
2.8200
Bid
2.8300
Ask
2.8330
Low
2.7890
High
2.8450
Volume
288
Open full chart

Financials

Overview Relevé Statistics
Quarterly Annual
Income statement Balance sheet Cash flow
Value Q3, 24Q4, 24Q1, 25Q2, 25Q3, 25

Protalix BioTherapeutics Inc (DE)

Protalix BioTherapeutics is an Israeli pharmaceutical company that manufactures a plant-based enzyme, taliglucerase alfa, which has received U.S. Food and Drug Administration approval for the treatment of Gaucher disease.

Nouvelles